<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2016-04-14">April 14, 2016.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD, MPH</roleName><forename type="first">Linus</forename><surname>Grabenhenrich</surname></persName>
							<email>linus.grabenhenrich@charite.de</email>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Lars</forename><surname>Lange</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department for Pediatrics</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Pneumology and Immunology</orgName>
								<orgName type="institution" key="instit1">St Marien-Hospital</orgName>
								<orgName type="institution" key="instit2">Bonn; c Charit e -Universit€ atsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department for Pediatrics</orgName>
								<orgName type="institution">German Red Cross Hospital</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Magdalena</forename><surname>H€ Artl</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Birgit</forename><surname>Kalb</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Mandy</forename><surname>Ziegert</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Antje</forename><surname>Finger</surname></persName>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Department for Pediatrics</orgName>
								<orgName type="department" key="dep2">Department of Pediatric Pneumology and Immunology</orgName>
								<orgName type="institution" key="instit1">St Marien-Hospital</orgName>
								<orgName type="institution" key="instit2">Bonn; c Charit e -Universit€ atsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Department for Pediatrics</orgName>
								<orgName type="institution">German Red Cross Hospital</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Neda</forename><surname>Harandi</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Children&apos;s Hospital</orgName>
								<address>
									<settlement>Wangen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ruppert</forename><surname>Schlags</surname></persName>
							<affiliation key="aff4">
								<orgName type="institution">Children&apos;s Hospital</orgName>
								<address>
									<settlement>Wangen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Monika</forename><surname>Gappa</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Children&apos;s Department</orgName>
								<orgName type="institution">Marien-Hospital</orgName>
								<address>
									<settlement>Wesel</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Letizia</forename><surname>Puzzo</surname></persName>
							<affiliation key="aff5">
								<orgName type="department">Children&apos;s Department</orgName>
								<orgName type="institution">Marien-Hospital</orgName>
								<address>
									<settlement>Wesel</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Volker</forename><surname>Stephan</surname></persName>
							<affiliation key="aff6">
								<orgName type="institution">Children&apos;s Hospital Lichtenberg</orgName>
								<address>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Thomas</forename><surname>Heigele</surname></persName>
							<affiliation key="aff7">
								<orgName type="institution">Children&apos;s Hospital</orgName>
								<address>
									<settlement>Stuttgart</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Susanne</forename><surname>B€</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Hagen</forename><surname>Ott</surname></persName>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department for Pediatrics</orgName>
								<orgName type="department" key="dep2">Icahn School of Medicine at Mount Sinai</orgName>
								<orgName type="institution" key="instit1">Children&apos;s Hospital Osnabr€ uck</orgName>
								<orgName type="institution" key="instit2">Osnabr€ uck; j Children&apos;s Hospital Auf der Bult</orgName>
								<address>
									<settlement>Hannover</settlement>
									<region>New York</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Bodo</forename><surname>Niggemann</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Kirsten</forename><surname>Beyer</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<address>
									<addrLine>Osnabr€ uck, and Hannover</addrLine>
									<settlement>Berlin, Bonn, Wangen, Wesel, Stuttgart, Germany, New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="department">Institute for Social Medicine, Epidemiology and Health Economics</orgName>
								<address>
									<settlement>Charit e -Universit€ atsmedizin Berlin, Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<orgName type="department">Institute for Social Medicine, Epidemiology and Health Economics</orgName>
								<address>
									<addrLine>Luisenstrasse 57</addrLine>
									<postCode>10117</postCode>
									<settlement>Charit e -Universit€ atsmedizin Berlin, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">The component-specific to total IgE ratios do not improve peanut and hazelnut allergy diagnoses</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2016-04-14">April 14, 2016.</date>
						</imprint>
					</monogr>
					<idno type="MD5">D78393184C12D1263602FE0F9F8AF3DE</idno>
					<idno type="DOI">10.1016/j.jaci.2016.01.043</idno>
					<note type="submission">Received for publication July 24, 2015; revised November 17, 2015; accepted for publication January 13, 2016.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Food hypersensitivity</term>
					<term>IgE</term>
					<term>Ara h 2 allergen</term>
					<term>peanut</term>
					<term>Cor a 14 allergen</term>
					<term>hazelnut</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Specific IgE measurement predicts the outcome of oral food challenges with considerable uncertainty when evaluating food allergy.</s><s>Objective: Our aim was to assess whether accounting for the ratio of component-or allergen-specific to total IgE can improve this prediction.</s><s>Methods: This multicenter study collected blood samples from children with suspected peanut or hazelnut allergy referred to allergy specialist clinics for food challenges.</s><s>Specific IgE to peanuts, hazelnuts, and their components (</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>A food allergy can only be reliably diagnosed or ruled out with an oral food challenge. <ref type="bibr" target="#b0">1</ref></s><s>With the aim of reducing the time and resources spent on these time-consuming and risky procedures, several screening methods have been evaluated to identify subjects with a very low probability of symptom development on food exposure or subjects in whom a food allergy is almost certain.</s><s>]<ref type="bibr" target="#b3">[4]</ref> These single-predictor approaches come with a considerable error rate, which has led to the development of more sophisticated, multidimensional, or stratified diagnostic tools.</s><s>Including information, such as age, sex, or previous symptoms, increases the predictive performance. <ref type="bibr" target="#b4">5</ref></s><s>Therefore sensitization not only to any protein of a given food but also to a defined single protein, which is also known as component-resolved diagnosis (CRD), <ref type="bibr" target="#b5">6</ref> can further improve the value of these models. <ref type="bibr" target="#b6">7</ref></s><s>]<ref type="bibr" target="#b11">[12]</ref><ref type="bibr" target="#b12">[13]</ref> Implications of a given specific IgE level might depend on the total IgE level, which is a potential indicator of atopy. <ref type="bibr" target="#b13">14</ref></s><s>7]<ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref> Whether accounting Abbreviations used AUC: Area under the curve CRD: Component-resolved diagnosis for total IgE improves the diagnostic accuracy of componentspecific IgE measurement has not been evaluated.</s><s>This analysis initially aimed to assess the diagnostic characteristics of the relative Ara h 2-and Cor a 14-specific IgE fractions in relation to peanut-and hazelnut-specific or total IgE levels in a pediatric population, which helped identify subjects who could be safely omitted from a peanut/hazelnut challenge.</s><s>The fraction of other peanut and hazelnut component-specific IgE levels and whole allergen-specific IgE levels were assessed and compared with the diagnostic performance of the raw specific IgE level.</s><s>The complementing test-inherent characteristics (eg, the sensitivity, specificity, and predictive values) and pointwise probabilities for a positive challenge outcome were also estimated to improve the applicability.</s><s>In addition to analysis of fractions, other approaches to account for total IgE were assessed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study design and setting</head><p><s>Nine study centers across Germany (centers in Bonn, Wangen, Wesel, Stuttgart, Osnabr€ uck, and Hamburg, as well as 3 centers in Berlin) performed between 7 and 100 food challenges in children suspected of having peanut or hazelnut food allergy. <ref type="bibr" target="#b9">10</ref></s><s>Blood was drawn before the challenge to assess the predictive value of total, peanut/hazelnut-specific, and CRD IgE levels.</s><s>Parents provided written informed consent.</s><s>The local ethics committees for each study center approved the study separately.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Population</head><p><s>Only children referred to pediatric allergy clinics for a first evaluation to demonstrate or exclude peanut allergy, hazelnut allergy, or both were eligible to participate in this study.</s><s>Challenges performed to monitor already diagnosed food allergy or to prove oral tolerance were excluded from this analysis.</s><s>There were no restrictions in terms of comorbidities or demographic characteristics, including age.</s><s>In general, study physicians were following current international guidelines in their decision to perform a food challenge. <ref type="bibr" target="#b19">20,</ref><ref type="bibr" target="#b20">21</ref></s><s>In detail, the inclusion criteria were as follows.</s><s>First was sensitization to peanut or hazelnut, such as in children with atopic dermatitis who have never eaten peanut or hazelnut.</s><s>The sensitization level (specific IgE level or skin prick test wheal size) was not accounted for as a selection criterion in these children.</s><s>Second was a recent immediate-type reaction in which peanut or hazelnut was suspected as the causative agent.</s><s>However, children with a severe reaction (anaphylaxis) within the last year to the first isolated consumption of peanut or hazelnut who were sensitized did not undergo food challenge testing.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IgE measurements</head><p><s>Venous blood samples were stored at 2208C and shipped on dry ice.</s><s>The total IgE level was determined for all of the participating children.</s><s>In the suspected peanut allergy cases, specific IgE levels against whole peanuts and 4 peanut proteins (Ara h 1, 2, 3, and 8) were measured, and for the suspected hazelnut allergy cases, IgE levels against whole hazelnuts and 4 hazelnut proteins (Cor a 1, 8, 9, and 14) were measured.</s><s>IgE levels were determined by using a fluorescence enzyme immunoassay (ImmunoCAP 100 System; Thermo Fisher, Uppsala, Sweden), with a test-inherent upper detection limit of 100 kU/L only for the specific measurements.</s><s>After all challenges were completed, analyses were performed at the study's central laboratory in Charit e Berlin, Germany.</s><s>Only total and whole peanut-or hazelnut-specific IgE levels measured at individual study centers using the same laboratory system were not determined again in the central laboratory.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Oral food challenges</head><p><s>Families were asked to discontinue the use of antihistamines 3 days before the food challenge.</s><s>Native roasted peanuts and raw hazelnuts were blinded in a chocolate mousse and fed in increasing doses over 30-minute intervals (target protein amounts were 3 mg, 10 mg, 30 mg, 100 mg, 300 mg, 1 g, and 3 g) under clinical supervision and standby emergency assistance.</s><s>The challenge meal ingredients were prepared centrally, distributed to each study center, and made ready for consumption on site on the day of the challenge.</s><s>A positive challenge outcome was defined by objective clinical reactions (eg, urticaria/angioedema, vomiting/diarrhea, wheezing/stridor, rhinitis/conjunctivitis, and a decrease in blood pressure) during the procedure or as long as 120 minutes after the final dose, according to recent suggestions for food challenge interpretation. <ref type="bibr" target="#b19">20</ref></s><s> negative challenge outcome was ascertained by eating a cumulative dose (4.4-g protein content) without symptoms on the following day, proving clinical tolerance. <ref type="bibr" target="#b21">22</ref></s><s>Interpretation of final challenge outcomes was independent of component-specific IgE levels because they were measured centrally after the clinical database was closed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analyses</head><p><s>The data set used for analyses consisted of children with available results for total IgE, Ara h 2, or Cor a 14 measurements; a defined challenge outcome (positive or negative); age (in months); and sex.</s><s>Raw IgE measures are illustrated on log-scaled axes (base 10); values of less than 0.01 kU/L (including 0) and greater than 100 kU/L (upper detection limit) were shifted into these boundaries.</s><s>Ratio measures were reported as percentages (multiplied by 100).</s><s>By accounting for the ratio measure distributions with total IgE levels as the denominator, the data were transformed to the fifth root for</s></p><p><s>).</s><s>This impeded the ratio measure calculations with a specific IgE denominator, and these values were treated as missing data.</s><s>All ratio measures were transformed by taking the logarithm (base 10) of their odds when they were used as independent variables in the logistic models: log 10 ratio/(1-ratio).</s></p><p><s>Although it was not formally required for the predictor variables, this approach yielded relatively symmetric and unskewed distributions.</s><s>When the numerator was zero (odds 5 0) or the transformed values were less than 10E-6, the variables were set to 10E-6.</s><s>If a numerator was equal to or even greater than the denominator (odds &gt; _ 1) or transformed values were greater than 10E2, then the variables were set to 10E2.</s><s>The total IgE levels were categorized at approximate tertile boundaries of the investigated population (100 and 500 kU/L).</s><s>Associations between baseline characteristics and total IgE levels were assessed through linear regression models on log-transformed total IgE levels and between baseline characteristics and challenge outcome through the Fisher exact test (sex, comorbidities, and raw/roasted foods) and Mantel-Haenszel test for linear association (age).</s></p><p><s>The central tendency of the raw and ratio measures was described with medians, and the spread was described with interquartile ranges.</s><s>Discriminations were assessed through c-statistic calculations (area under the curve [AUC]) from the univariate logistic models, including 95% CIs.</s><s>To compare and discriminate the single predictors with complete models, multivariate logistic models were applied, and contrasts were assessed through statistical testing (hypothesis: the complete and univariate models would discriminate equally well).</s><s>A continuous estimation of the test characteristics (sensitivity, specificity, and prediction probability at the given levels and positive and negative predictive values greater than/less than the given cutoffs) was based on univariate logistic modeling of actual cases and scoring the model at predefined levels.</s></p><p><s>Sensitivity analyses were used to assess the following subgroups: comorbid eczema, boys, age of 4 years or greater, single study center, and challenge blinding mode.</s><s>Additionally, challenge outcomes were recoded to only account for more severe objective symptoms (eg, generalized urticaria, repeated vomiting, respiratory arrest, and decreases in blood pressure).</s><s>The lower and upper boundaries for log odds-transformed ratio measures that were used as independent variables were set to different levels (the lower boundary was initially 10E-6 but was also assessed at 10E-4, 10E-5, 10E-7, and 10E-8; the upper boundary was initially 10E-2 but was assessed at 10E-3 and 10E-4 exponents).</s><s>Missing values for the ratio measures were set to the lower boundary, and missing values for whole allergen-specific IgE were set to 0.1 kU/L.</s><s>Baseline characteristics were compared by using the Fisher exact test.</s><s>All of the computations were evaluated with SAS 9.3 software (SAS Institute, Cary, NC).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Population and food challenges</head><p><s>The allergen-and component-specific IgE levels were determined for 207 children with suspected peanut allergies, and their median age was 4.6 years (interquartile range, 2.1-7.7 years).</s><s>One hundred forty-seven (71%) had atopic eczema, which included 76 (37%) girls.</s><s>Eighty-eight (43%) had symptoms on oral peanut exposure, which was most frequently generalized as urticaria (n 5 49 [56%]) and vomiting (n 5 28 [32%]).</s><s>One hundred fortytwo children were evaluated for hazelnut allergies, and their median age was 4.5 years (interquartile range, 2.1-7.6 years).</s><s>One hundred three (73%) had eczema, which included 45 (32%) girls.</s><s>Forty-four (31%) had symptomatic responses after the hazelnut food challenge, which included generalized urticaria (n 5 29 [66%]) and vomiting (n 5 10 [23%]).</s><s>One hundred twenty-one (35%) of the total 349 challenges were single-or double-blind, of which 36% resulted in a positive outcome compared with the open challenges, in which 39% of the subjects had symptoms (Table <ref type="table" target="#tab_0">I</ref>).</s><s>Fewer girls (31% vs 42%, P 5.034), more asthmatic patients (40% vs 22%, P &lt; .001),</s><s>and fewer children with total IgE levels of less than 100 kU/L (22% vs 38%, P 5 .003)</s><s>underwent open challenges (details are shown in Table <ref type="table" target="#tab_6">E1</ref> in this article's Online Repository at www.jacionline.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>IgE</head><p><s>The Ara h 2-specific IgE level was lower in the tolerant children than in the children with peanut allergy (median, 0.03 vs 6.5 kU/L, respectively), which was also observed with Ara h 2-specific/total IgE ratios (median, 0.01% vs 3.2%, respectively).</s><s>Similarly, the Cor a 14-specific IgE level was lower in the tolerant children compared with that in the children with hazelnut allergy (median, 0.04 vs 6.2 kU/L, respectively), and a median Cor a 14-specific/ total IgE ratio of 0.02% was seen in the tolerant cases compared with 1.4% in the hazelnut allergy cases.</s><s>With the overlapping distributions, neither the raw nor ratio measures completely discriminated between the challenge outcomes (Fig <ref type="figure" target="#fig_0">1</ref>).</s></p><p><s>In the peanut-tolerant children only 20.1% of the whole peanutspecific IgE (median, 1.3 kU/L; complete data for 191/207) was explained by the 4 components assessed and mainly by Ara h 1 (7.7%) and Ara h 8 (8.2%).</s><s>With the children with peanut allergy,on the other hand, 70.5% of the peanut-specific IgE (median, 16.8 kU/L) could be attributed to individual proteins, and 55.6% of the peanut-specific IgE could be attributed to Ara h 2 alone.</s><s>In the hazelnut group 54.9% of the whole hazelnut-specific IgE (median, 3.2 kU/L; complete data for 130/142) was explained by components in the tolerant children, with Cor a 1-specific IgE accounting for 46.1% of the hazelnut-specific IgE.</s><s>In the children with hazelnut allergy, all 4 components summed up to 82.7% of hazelnut-specific IgE (median, 14.2 kU/L), with 54.3% attributed to the Cor a 14-specific IgE (a detailed description of the raw/ratio measures are shown in Table <ref type="table" target="#tab_1">II</ref>, left columns).</s></p><p><s>Within each low, medium, and high total IgE group (&lt;100, 100-500, and &gt;500 kU/L, respectively), the median specific IgE value was higher in allergic compared with the tolerant children for Ara h 1-, Ara h 2-, Ara h 3-, and peanut-specific levels, as well as Cor a 9-, Cor a 14-, and hazelnut-specific IgE levels.</s><s>The specific IgE levels were higher with increasing total IgE levels for all of the assessed measures, indicating that a stratified approach by total IgE might be useful (see Figs E1 and E2 in this article's Online Repository at www.jacionline.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Performance measures</head><p><s>The discriminative performance of the Ara h 2-specific IgE/ total IgE ratio was as high as that of Ara h 2-specific IgE alone (AUC, 0.92 vs 0.93) and better than all of the other assessed raw/ ratio measures (Table <ref type="table" target="#tab_1">II</ref>, right columns).</s><s>Comparing ratio measures to predict peanut challenge outcomes in a single model revealed that the Ara h 2-specific/total IgE ratio alone performed as well as the complete model, which included the Ara h 2-specific/ peanut IgE and peanut-specific/total IgE ratios (P 5 .921;</s><s>Fig <ref type="figure" target="#fig_2">2</ref>, left panel).</s><s>The discrimination of hazelnut challenge outcome through the Cor a 14-specific/total IgE ratio worked as well as the raw Cor a 14 values (AUC, 0.87 vs 0.89); however, these</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Food challenge outcome predictions</head><p><s>Nine (90%) in 10 peanut challenges were predicted to be positive at an Ara h 2-specific/total IgE ratio of 6.1%, and 1 (10%) in 10 were predicted to be positive at a ratio of 0.01%.</s><s>With the sample's prevalence for a positive peanut challenge outcome (43%), 96% of all the children with a ratio of 6.1% or greater were estimated to have symptoms (positive predictive value).</s><s>The negative predictive value at a ratio of 0.01% was 98% (Fig <ref type="figure" target="#fig_3">3</ref>, left panel).</s><s>Five children with negative challenge outcomes actually decreased to greater than the 90% probability level (C-G in Fig <ref type="figure" target="#fig_3">3</ref>), and all of them had considerable peanut-specific IgE levels (1.1 to &gt;100 kU/L) and no other known food allergies.</s><s>Children who were falsely labeled with allergies that were based on component-specific IgE levels might still be at increased risk for food allergies that were not apparent with the challenge (eg, augmenting factors, dosing, and challenge matrices).</s><s>Two children with a positive peanut challenge decreased to less than the 10% probability level: a 2-year-old boy (A in Fig 3) with comorbid hen's egg allergy that was not sensitized to Ara h 2 but to Ara h 3 (0.6 kU/L) and a 6-year-old boy (B in Fig <ref type="figure" target="#fig_3">3</ref>) with a peanut-specific IgE level of 3.2 kU/L who could not be assigned to the assessed components.</s></p><p><s>In light of the reported symptoms, this was probably a case of food protein-induced enterocolitis syndrome (Table <ref type="table" target="#tab_2">III</ref>, upper portion).</s><s>When accounting only for the raw Ara h 2-specific IgE levels to predict 10% or 90% positive challenge outcomes (0.03 and 14.4 kU/L, respectively, as estimated in Beyer et al <ref type="bibr" target="#b9">10</ref> ), 1 additional child who was truly allergic to peanut would have been missed because of relatively low total IgE levels (61 kU/L).</s><s>On the other hand, using the ratio measure (Ara h 2-specific/total IgE) yielded more false-positive results (5 vs 2).</s></p><p><s>A 90% probability for a positive hazelnut challenge was estimated at a Cor a 14-specific/total IgE ratio of 18.4%; however, no actual cases (positive or negative) were greater than that level.</s><s>An 80% probability could be estimated at a 5.7% ratio, and a 10% probability could be estimated at a 0.02% ratio.</s><s>With the actual prevalence (31%) of a positive hazelnut challenge, 91% (positive predictive value) of the children were estimated to show symptoms at or greater than the 80% probability level of 5.7%, and 96% (negative predictive value) were expected to be tolerant at less than the 10% level of a Cor a 14-specific/total IgE ratio of 0.02% (Fig <ref type="figure" target="#fig_3">3</ref>  <ref type="table" target="#tab_2">III</ref>, lower portion).</s><s>Only these 2 children would have also been missed when applying a cutoff at 0.05 kU/L to the raw Cor a 14-specific IgE measurement, which was estimated to yield a 10% probability for a positive hazelnut challenge. <ref type="bibr" target="#b9">10</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Subgroup analyses</head><p><s>Rerunning prediction models within eczema and male subgroups produced similar positive challenge outcome probabilities.</s><s>In the older children (&gt; _4 years) the assessed ratio measures discriminated slightly better between the challenge outcomes, with higher probabilities at ratios of 10% and lower probabilities at ratios of 0.01% compared with the whole samples, especially for Cor a 14 (Table <ref type="table" target="#tab_3">IV</ref>).</s><s>An estimation of the predicted probabilities at given component/total IgE ratios were robust against case definition variations (ie, only selected objective reactions), food challenge types (double-blind vs open), and coding strategies (eg, handling of outliers, missing values, and values outside of the detection borders [results not shown]).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Other approaches accounting for total IgE</head><p><s>Including total IgE, either log-transformed or categorized in tertiles, did not improve discrimination but did contribute to logistic models with raw component-specific IgE, significantly for Ara h 2 and at less than formal significance for Cor a 14 (models 3 and 4 in Table <ref type="table" target="#tab_4">V</ref>).</s><s>The predicted probability for a positive challenge outcome at a given component-specific IgE level was dependent on the total IgE level, especially at lower component-specific IgE levels.</s><s>For example, with an Ara h 22specific IgE level of 0.35 kU/L, the probability for a peanut challenge reaction was only 16% when the total IgE level was high (&gt;500 kU/L) compared with 51% or 48% when the total IgE level was low or medium (&lt;100/100-500 kU/L), respectively.</s><s>Similarly, the probability for a positive hazelnut challenge with a Cor a 14-specific IgE level of 0.35 kU/L was only 7% when the total IgE level was high compared with 34% or 32% when the total IgE level was low or medium, respectively (Fig <ref type="figure">4</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Baseline characteristics, total IgE levels, and challenge outcomes</head><p><s>Only age was significantly associated with total IgE levels (P &lt; .001)</s><s>but not with sex, eczema, or other comorbidities (see Table <ref type="table" target="#tab_7">E2</ref> in this article's Online Repository at www.jacionline.</s><s>org).</s><s>On the other hand, baseline characteristics were not associated with the challenge outcome; that is, they did not change the prior probability for test results in strata by age, sex, or comorbidities (see Table <ref type="table" target="#tab_8">E3</ref> in this article's Online Repository at www.jacionline.org).</s><s>Thus the role of total IgE for the prediction of challenge outcomes was not dependent on other factors assessed in this study (see Fig E4 in this article's Online Repository at www.jacionline.org).</s><s>Prediction in strata of age (0-1/2-5/&gt; _6 years) was similar for Ara h 2-specific IgE, but a positive hazelnut challenge at a given Cor a 14-specific IgE level was less probable in school-aged children compared with preschoolers, reflecting their higher total IgE levels (see Fig <ref type="figure">E5</ref> in this article's Online Repository at www.jacionline.org).</s><s>Finally, age and eczema did not significantly contribute to the prediction models with component-specific and total IgE (models 5 and 6 in Table <ref type="table" target="#tab_4">V</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION CRD</head><p><s>Raw Ara h 2-and Cor a 14-specific IgE concentrations alone had been shown to be as informative as all of the components and whole allergen-specific IgE levels combined to predict outcomes of oral peanut/hazelnut challenges. <ref type="bibr" target="#b9">10</ref></s><s>Similar to raw concentrations, Ara h 2-and Cor a 14-specific total IgE fractions were much lower in the tolerant (0.01% and 0.02%, respectively) compared with allergic (3.2% and 1.4%, respectively) children.</s><s>Both of the ratio measures discriminated as well as the raw concentrations, with AUCs of 0.92/0.93</s><s>(ratio/raw) for Ara h 2-specific IgE and 0.87/0.89</s><s>(ratio/raw) for Cor a 14-specific IgE.</s><s>The addition of other ratio measures, including component/allergen-specific IgE and allergen-specific/total IgE (Fig 2 <ref type="figure">)</ref>, did not improve the challenge outcome predictions in this population.</s><s>Other studies reported similar discriminations for Ara h 2-specific IgE (AUC, 0.90-0.99 <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12,</ref><ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b23">24</ref></s><s>) and Cor a 14-specific IgE (AUC, 0.80 <ref type="bibr" target="#b12">13</ref> ).</s><s><ref type="table" target="#tab_2">III</ref>.</s></p><p><s>Other assessed component ratios discriminated worse than Ara h 2 and Cor a 14 values; however, each one was as good as its raw concentration.</s><s>For peanuts, the median ratio was considerably higher in the allergic than in the tolerant children for Ara h 1 (0.5% vs 0.03%), with an AUC of 0.80/0.80 for ratio/raw measures, respectively.</s><s>In patients with suspected hazelnut allergies, the Cor a 9 values discriminated well (AUC, 0.76/ 0.80), with median ratios of 0.6% versus 0.05% when comparing the allergic and nonallergic children.</s><s>These ratios did not seem to inform the decision to omit a food challenge above what was already known through the raw Ara h 2-and Cor a 14-specific IgE levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Whole allergen-specific IgE</head><p><s>Whole allergen-specific to total IgE ratios were lower in tolerant children than in allergic children: 0.4% versus 6.4%, respectively, for suspected peanut allergies and 1.7% versus 4.4%, respectively, for suspected hazelnut allergies.</s><s>Peanut allergy was the only other analysis (with a comparable age distribution, n 5 50) that reported similar results for tolerant (0.4%) but lower numbers for allergic (2.4%) children.</s><s>In this report the hazelnut-specific/total IgE ratio was much lower (n 5 32) than in our sample, which included median ratios of 0.3% for tolerant and 1.9% for allergic children. <ref type="bibr" target="#b15">16</ref></s><s>he ratio measure discrimination was very good for peanutspecific IgE levels and similar to the raw concentrations (AUCs, 0.84 and 0.83, respectively).</s><s>The hazelnut-specific/total IgE ratio measure, on the other hand, performed worse than the actual hazelnut-specific IgE level itself (0.66 and 0.71, respectively).</s><s>On the contrary, the recent analysis cited above reported much better discrimination for their ratio measures, with peanut AUCs of 0.78 versus 0.56 and hazelnut AUCs of 0.85 versus 0.60 (ratio vs raw, respectively).</s><s>Note that the raw levels used in the logistic models were not transformed in that report. <ref type="bibr" target="#b15">16</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Specific IgE fraction</head><p><s>In allergic children the major part of the whole allergen-specific IgE could be attributed to the 4 assessed components, which were included in 70.5% of cases of peanut allergy and 82.7% of cases of hazelnut allergy, with the remaining probably attributable to peanut/hazelnut proteins, which were not determined.</s><s>In relation to the whole peanut/hazelnut-specific IgE levels, the main components, Ara h 2-and Cor a 14-specific IgEs, respectively, had fractions of 55.6% and 54.3% in allergic children compared with 1.9% and 1.5% in nonallergic children, respectively.</s><s>Both of the ratio measures discriminated worse than the total IgE fraction or the raw concentrations.</s><s>Our analyses suggest that accounting for whole allergen-specific IgE levels did not considerably improve the discriminations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Clinical prediction</head><p><s>In addition to the commonly reported (positive/negative) predictive values, we reported pointwise and continuously estimated probabilities for challenge outcomes (Figs <ref type="figure" target="#fig_3">3 and 4</ref>).</s><s>These values could be used in similar clinical settings and were expected to reflect the information given by a specific level of a single predictor.</s><s>Of note, all of the reported measures are dependent on a sample's proportion of positive challenge  outcomes and the prevalence (a priori probability). <ref type="bibr" target="#b24">25</ref></s><s>For example, with an Ara h 2-specific/total IgE ratio of approximately 6%, 9 in 10 challenges in a comparable sample would become symptomatic.</s><s>A Cor a 14-specific/total IgE ratio of 6% predicted only 8 of 10 assessed children would become symptomatic.</s><s>Additionally, all of the children with Ara h 2-or Cor a 14-specific to total IgE ratios that were at or greater than the 6% cutoff would become symptomatic in 96% or 91% of the cases, respectively (positive predictive values).</s></p><p><s>When applying ratio measures for predicting challenge outcomes, almost the same nonallergic children were wrongly labeled as having positive results based on high componentspecific/total IgE ratios (false-positive results), and the same allergic children were missed during screening because of low ratio measures (false-negative results) compared with predictions based on raw component levels. <ref type="bibr" target="#b9">10</ref></s><s>The ratio measures did not noticeably decrease the prediction error rate, and they were of no additional use for predicting peanut/hazelnut challenge outcomes.</s><s>We suggest the use of raw component-specific IgE levels and to derive individual probabilities from continuous prediction models to guide further diagnostic steps. <ref type="bibr" target="#b9">10</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Other approaches accounting for total IgE</head><p><s>With high total IgE levels (&gt;500 kU/L), the probability of a positive challenge outcome was considerably lower than the estimated outcome from the overall model (Fig <ref type="figure">4</ref>).</s><s>Thus with relatively low component-specific IgE levels (Ara h 2/Cor a 14-specific IgE levels of 0.1 to 1 kU/L), a high total IgE level (&gt;500 kU/ L) might help to decide whether to perform a food challenge.</s><s>In contrast to the initially assessed fractions, which did not improve the prediction of challenge outcomes, a stratified approach based on total IgE measurements could help to discriminate between probable food allergy and tolerance given specific IgE levels.</s><s>These predictions are independent of age, sex, eczema, and other comorbidities in this population.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Strengths and limitations</head><p><s>The reported estimates were derived from a pragmatic sample of children who were routinely evaluated for peanut/hazelnut food allergies in various specialist clinics throughout Germany, which supports its application in diverse settings.</s><s>Nonetheless, prior information on sensitization is expected to influence recruitment and should be kept in mind for the interpretation of reported test characteristics.</s><s>We altered how the predictive measures were calculated and transformed and how the outcomes were defined, and we assessed the model performance in substrata of the complete samples to demonstrate the estimate's robustness.</s><s>The value of the ratio measures was only assessed in a pediatric population, and a similar analysis should be repeated for adults and with food allergens other than peanuts and hazelnuts.</s><s>Estimated probabilities and other performance measures, such as (positive/negative) predictive values, are dependent on the ratio of allergic to nonallergic subjects, which stresses the need for study replication in other clinical settings and regions.</s><s>We cannot rule out that children with very high total IgE levels (and eczema) were selected to undergo food challenge testing even without a convincing history and therefore with a low probability to react during the challenge.</s><s>This association could lead to the false impression that high total IgE levels might be protective against food allergy.</s><s>Notably, the reported estimates were derived from only the first challenges for a given allergen, and componentspecific IgE fractions or raw levels might be of a different value for long-term monitoring of a confirmed food allergy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusion</head><p><s>Calculating the component-specific to total IgE ratio could not improve the discriminative and predictive performances of the CRD in the workup of pediatric patients with suspected peanut and hazelnut allergies above what can be achieved with raw Ara h 2-and Cor a 14-specific IgE levels.</s><s>However, the latter might be improved by total IgE because the probability of a positive food challenge based on component-specific IgE was considerably lower within the stratum of high total IgE levels (&gt;500 kU/L) independent of age, eczema, and other comorbidities.</s></p><p><s>We thank the families and children for their participation.</s><s>Without the clinical staff in the participating allergy clinics, the supervising of food challenges, and the documenting of patient symptoms and histories, we would not have finished this project.</s><s>We are indebted to Gabi Schulz and Alexander Rohrbach (Berlin, Germany) for their meticulous laboratory work.</s><s>We thank all persons involved in the ''Interest Group Food Allergy'' of the German Society for Pediatric Allergology (GPA).</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. Component-specific IgE levels versus component-specific to total IgE ratio distributions by food challenge outcome.</s><s>Left, Ara h 2-specific IgE and peanut challenge outcomes.</s><s>Right, Cor a 14-specific IgE and hazelnut challenge outcomes.</s><s>Red solid circles, Positive challenge outcome; green open circles, negative challenge outcome.</s><s>The raw component axis (x-axis) is log-scaled, and the proportional axis (y-axis) is scaled to the fifth root.</s><s>The corresponding percentiles are interpolated with a gray line and penalized splinesmoothed to the second degree (isopercentile).</s><s>Marginal box-and-whisker plots by challenge outcome are shown, with labeled group medians.</s><s>In each panel/group 2 cases with a component-specific IgE level of 0 kU/L but a positive challenge outcome are shown (lower left corner, red solid circle).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>, right panel).</s><s>Only 2 children with a positive hazelnut challenge actually fell to less than this level: a 1-year-old boy (H in Fig 3) with no hazelnut-specific IgE levels and a 2-yearold boy (I in Fig 3) with a comorbid hen's egg allergy who was not sensitized to Cor a 14 but only to Cor a 9 (1.4 kU/L of 1.6 kU/L whole hazelnut IgE; Table</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. Receiver operating characteristic curves predicting positive challenge outcomes for peanut (left) and hazelnut (right) food allergies (n 5 191 peanut allergies and n 5 130 hazelnut allergies in the model).</s><s>Complete models (multivariate, gray lines, and shaded areas) are comprised of the 3 listed IgE ratio measures.</s><s>Solid blue line, Component/total IgE ratio; dashed blue line, component/specific; black line, and specific/total ratio.</s><s>Raw component measures were included as a comparison (orange line).</s><s>In the tables areas under curve (AUC), including 95% CIs, are shown.</s><s>*Significance tests for equal AUCs of the complete logistic model (reference category) and single ratio measures.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 3 .</head><label>3</label><figDesc><div><p><s>FIG 3. Predicted probabilities for positive peanut (upper panel) and hazelnut (lower panel) challenge outcomes (blue line and confidence bands) at component-specific/total IgE ratios.</s><s>Upward-pointing arrows, Estimated component/total IgE ratios that yielded prespecified prediction probabilities (10%, 20%, 80%, and 90%) from the univariate logistic models.</s><s>Continuous modeling of the positive predictive value (PPV; red) and negative predictive value (NPV; green) is shown.</s><s>Gray circles indicate actual cases.</s><s>Plus signs in the top panels represent actual children by challenge outcomes.</s><s>A-I indicate exceptions that are further detailed in TableIII.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG</head><label></label><figDesc><div><p><s>FIG 4. Predicted for a positive peanut (upper panel) or hazelnut (lower panel) challenge outcome with Ara h 2-or Cor a 14-specific IgE levels by strata of low, medium, and high total IgE levels (approximate tertiles).</s><s>Number of peanut challenges in the low, medium, and high total IgE strata were 53, 86, and 68, respectively.</s><s>Number of hazelnut challenges in the low, medium, and high total IgE strata were 44, 61, and 37, respectively.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>TABLE I .</head><label>I</label><figDesc><div><p><s>Baseline characteristics by assessed allergen</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell>Peanut</cell><cell></cell><cell>Hazelnut</cell></row><row><cell></cell><cell></cell><cell>No.</cell><cell>Percent</cell><cell>No.</cell><cell>Percent</cell></row><row><cell></cell><cell>Total</cell><cell>207</cell><cell></cell><cell>142</cell><cell></cell></row><row><cell></cell><cell>Female sex</cell><cell>76</cell><cell>36.7</cell><cell>45</cell><cell>31.7</cell></row><row><cell></cell><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>0-1 y</cell><cell>42</cell><cell>20.3</cell><cell>27</cell><cell>19.0</cell></row><row><cell></cell><cell>2-3 y</cell><cell>47</cell><cell>22.7</cell><cell>35</cell><cell>24.6</cell></row><row><cell></cell><cell>4-5 y</cell><cell>46</cell><cell>22.2</cell><cell>32</cell><cell>22.5</cell></row><row><cell></cell><cell>&gt; _6 y</cell><cell>72</cell><cell>34.8</cell><cell>48</cell><cell>33.8</cell></row><row><cell></cell><cell>Comorbidities</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Atopic eczema</cell><cell>147</cell><cell>71.0</cell><cell>103</cell><cell>72.5</cell></row><row><cell></cell><cell>Asthma</cell><cell>67</cell><cell>32.4</cell><cell>50</cell><cell>35.2</cell></row><row><cell></cell><cell>Rhinoconjunctivitis</cell><cell>19</cell><cell>9.2</cell><cell>9</cell><cell>6.3</cell></row><row><cell></cell><cell>Other allergens challenged</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Peanut</cell><cell>-</cell><cell>-</cell><cell>88</cell><cell>62.0</cell></row><row><cell></cell><cell>Hazelnut</cell><cell>84</cell><cell>40.6</cell><cell>-</cell><cell>-</cell></row><row><cell></cell><cell>Almonds</cell><cell>15</cell><cell>7.2</cell><cell>18</cell><cell>12.7</cell></row><row><cell></cell><cell>Walnut</cell><cell>11</cell><cell>5.3</cell><cell>12</cell><cell>8.5</cell></row><row><cell></cell><cell>Hen's egg</cell><cell>70</cell><cell>33.8</cell><cell>61</cell><cell>43.0</cell></row><row><cell></cell><cell>Cow's milk</cell><cell>23</cell><cell>11.1</cell><cell>24</cell><cell>16.9</cell></row><row><cell></cell><cell>Soy</cell><cell>15</cell><cell>7.2</cell><cell>9</cell><cell>6.3</cell></row><row><cell></cell><cell>Wheat</cell><cell>10</cell><cell>4.8</cell><cell>4</cell><cell>2.8</cell></row><row><cell></cell><cell>Fish/crustaceans</cell><cell>7</cell><cell>3.4</cell><cell>5</cell><cell>3.5</cell></row><row><cell></cell><cell>Reacted to roasted allergen</cell><cell>179</cell><cell>(86.5)</cell><cell>18</cell><cell>12.7</cell></row><row><cell></cell><cell>Total IgE</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>&lt;100 kU/L</cell><cell>53</cell><cell>25.6</cell><cell>44</cell><cell>31.0</cell></row><row><cell>depiction. Other than for total IgE levels, whole peanut/hazelnut-specific IgE</cell><cell>100-500 kU/L</cell><cell>86</cell><cell>41.5</cell><cell>61</cell><cell>43.0</cell></row><row><cell>levels were determined at 0 kU/L for some children (peanut, n 5 16; hazelnut,</cell><cell>&gt;500 kU/L</cell><cell>68</cell><cell>32.9</cell><cell>37</cell><cell>26.1</cell></row><row><cell>n</cell><cell>Whole allergen-specific IgE</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>&lt;0.35 kU/L (CAP 0)</cell><cell>47</cell><cell>22.7</cell><cell>30</cell><cell>21.1</cell></row><row><cell></cell><cell>0.35 &lt; _ 0.70 kU/L (CAP I)</cell><cell>18</cell><cell>8.7</cell><cell>9</cell><cell>6.3</cell></row><row><cell></cell><cell>0.70 &lt; _ 3.5 kU/L (CAP II)</cell><cell>55</cell><cell>26.6</cell><cell>29</cell><cell>20.4</cell></row><row><cell></cell><cell>3.5 &lt; _ 17.5 kU/L (CAP III)</cell><cell>48</cell><cell>23.2</cell><cell>38</cell><cell>26.8</cell></row><row><cell></cell><cell>&gt; _17.5 kU/L (CAP IV-VI)</cell><cell>39</cell><cell>18.8</cell><cell>36</cell><cell>25.4</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>TABLE II .</head><label>II</label><figDesc><div><p><s>Central indexes (medians) and spreads (interquartile ranges) of the raw and ratio measures by challenge outcome</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="2">Oral food challenge</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>Negative</cell><cell></cell><cell>Positive</cell><cell></cell><cell></cell><cell></cell></row><row><cell>IgE</cell><cell>Median</cell><cell>Q1-Q3</cell><cell>Median</cell><cell>Q1-Q3</cell><cell>AUC</cell><cell>95% CI</cell></row><row><cell>Total (peanut samples)</cell><cell>230 kU/L</cell><cell>77-836</cell><cell>307 kU/L</cell><cell>127-894</cell><cell>0.54</cell><cell>0.46-0.62</cell></row><row><cell>Peanut</cell><cell>1.3 kU/L</cell><cell>0.3-4.1</cell><cell>16.8 kU/L</cell><cell>4.8-94.8</cell><cell>0.83</cell><cell>0.77-0.88</cell></row><row><cell>Total IgE (%)</cell><cell>0.40%</cell><cell>0.1-1.4</cell><cell>6.4%</cell><cell>2.0-16.0</cell><cell>0.84</cell><cell>0.79-0.90</cell></row><row><cell>Ara h 1</cell><cell>0.07 kU/L</cell><cell>0.04-0.2</cell><cell>0.9 kU/L</cell><cell>0.1-13.1</cell><cell>0.80</cell><cell>0.74-0.86</cell></row><row><cell>Total IgE (%)</cell><cell>0.03%</cell><cell>0.01-0.11</cell><cell>0.5%</cell><cell>0.06-3.9</cell><cell>0.80</cell><cell>0.74-0.86</cell></row><row><cell>Peanut IgE (%)</cell><cell>7.7%</cell><cell>2.4-17.9</cell><cell>11.4%</cell><cell>2.7-27.9</cell><cell>0.57</cell><cell>0.48-0.65</cell></row><row><cell>Ara h 2</cell><cell>0.03 kU/L</cell><cell>0.01-0.1</cell><cell>6.5 kU/L</cell><cell>1.7-53.4</cell><cell>0.93</cell><cell>0.89-0.97</cell></row><row><cell>Total IgE (%)</cell><cell>0.01%</cell><cell>0-0.03</cell><cell>3.2%</cell><cell>0.9-9.6</cell><cell>0.92</cell><cell>0.88-0.96</cell></row><row><cell>Peanut IgE (%)</cell><cell>1.9%</cell><cell>0.4-10.6</cell><cell>55.6%</cell><cell>24.7-95.6</cell><cell>0.87</cell><cell>0.82-0.93</cell></row><row><cell>Ara h 3</cell><cell>0.04 kU/L</cell><cell>0.01-0.09</cell><cell>0.2 kU/L</cell><cell>0.04-2.0</cell><cell>0.73</cell><cell>0.66-0.80</cell></row><row><cell>Total IgE (%)</cell><cell>0.01%</cell><cell>0.01-0.04</cell><cell>0.09%</cell><cell>0.02-0.5</cell><cell>0.74</cell><cell>0.67-0.81</cell></row><row><cell>Peanut IgE (%)</cell><cell>2.3%</cell><cell>1.0-5.6</cell><cell>2.2%</cell><cell>0.6-6.3</cell><cell>0.47</cell><cell>0.38-0.55</cell></row><row><cell>Ara h 8</cell><cell>0.1 kU/L</cell><cell>0.01-4.3</cell><cell>0.2 kU/L</cell><cell>0.02-10.3</cell><cell>0.53</cell><cell>0.45-0.61</cell></row><row><cell>Total IgE (%)</cell><cell>0.03%</cell><cell>0-1.3</cell><cell>0.09%</cell><cell>0-1.6</cell><cell>0.52</cell><cell>0.44-0.60</cell></row><row><cell>Peanut IgE (%)</cell><cell>8.2%</cell><cell>0.6-213.7</cell><cell>1.3%</cell><cell>0-44.6</cell><cell>0.60</cell><cell>0.52-0.68</cell></row><row><cell>Total (hazelnut sample)</cell><cell>180 kU/L</cell><cell>68-340</cell><cell>319 kU/L</cell><cell>178-889</cell><cell>0.65</cell><cell>0.55-0.74</cell></row><row><cell>Hazelnut</cell><cell>3.2 kU/L</cell><cell>0.5-16.8</cell><cell>14.2 kU/L</cell><cell>6.5-38.3</cell><cell>0.71</cell><cell>0.63-0.80</cell></row><row><cell>Total IgE (%)</cell><cell>1.70%</cell><cell>0.4-6.1</cell><cell>4.4%</cell><cell>1.8-8.4</cell><cell>0.66</cell><cell>0.57-0.75</cell></row><row><cell>Cor a 1</cell><cell>0.6 kU/L</cell><cell>0.01-12.6</cell><cell>0.6 kU/L</cell><cell>0.03-17.1</cell><cell>0.55</cell><cell>0.46-0.65</cell></row><row><cell>Total IgE (%)</cell><cell>0.4%</cell><cell>0-4.1</cell><cell>0.3%</cell><cell>0.01-3.2</cell><cell>0.52</cell><cell>0.42-0.62</cell></row><row><cell>Hazelnut IgE (%)</cell><cell>46.1%</cell><cell>1.3-100.0</cell><cell>6.4%</cell><cell>0.4-83.6</cell><cell>0.55</cell><cell>0.45-0.66</cell></row><row><cell>Cor a 8</cell><cell>0.02 kU/L</cell><cell>0-0.07</cell><cell>0.05 kU/L</cell><cell>0.01-0.2</cell><cell>0.62</cell><cell>0.52-0.72</cell></row><row><cell>Total IgE (%)</cell><cell>0.01%</cell><cell>0-0.02</cell><cell>0.01%</cell><cell>0-0.05</cell><cell>0.56</cell><cell>0.46-0.67</cell></row><row><cell>Hazelnut IgE (%)</cell><cell>0.3%</cell><cell>0-1.6</cell><cell>0.3%</cell><cell>0.1-1.7</cell><cell>0.51</cell><cell>0.41-0.61</cell></row><row><cell>Cor a 9</cell><cell>0.2 kU/L</cell><cell>0.01-0.7</cell><cell>2.3 kU/L</cell><cell>0.5-12.0</cell><cell>0.80</cell><cell>0.72-0.88</cell></row><row><cell>Total IgE (%)</cell><cell>0.05%</cell><cell>0.01-0.5</cell><cell>0.6%</cell><cell>0.3-2.5</cell><cell>0.76</cell><cell>0.67-0.84</cell></row><row><cell>Hazelnut IgE (%)</cell><cell>7.0%</cell><cell>0.1-54.2</cell><cell>21.7%</cell><cell>5.2-59.9</cell><cell>0.62</cell><cell>0.52-0.71</cell></row><row><cell>Cor a 14</cell><cell>0.04 kU/L</cell><cell>0.01-0.2</cell><cell>6.2 kU/L</cell><cell>1.0-22.2</cell><cell>0.89</cell><cell>0.83-0.95</cell></row><row><cell>Total IgE (%)</cell><cell>0.02%</cell><cell>0.01-0.1</cell><cell>1.4%</cell><cell>0.5-5.0</cell><cell>0.87</cell><cell>0.81-0.94</cell></row><row><cell>Hazelnut IgE (%)</cell><cell>1.5%</cell><cell>0.2-7.7</cell><cell>54.3%</cell><cell>14.1-86.5</cell><cell>0.85</cell><cell>0.79-0.92</cell></row></table><note><p><s>Discriminations (AUC) were based on univariate logistic modeling of challenge outcomes and include 95% CIs.Boldface indicates main predictors (Ara h 2-specific/total IgE ratio and Cor a 14-specific/total IgE ratio).Cases in peanut allergy models: n 5 207 for the total, components, and components/total evaluations; n 5 191 for all other.Cases in hazelnut allergy models: n 5 142 for the total, components and components/total evaluations; n 5 130 for all others.Q1, First quartile (25th percentile); Q3, third quartile (75th percentile).discriminationswere</s><s>not exceeded by any of the other raw/ratio measures.A logistic prediction that incorporated other ratio measures showed that the Cor a 14-specific/total IgE ratio alone performed as well as the complete model (P 5 .850;Fig2,</s><s>right  panel).</s><s>By using a cutoff of 0.1%, the performance in allergic children was very good (91% sensitivity for Ara h 2-specific/total IgE and 87% sensitivity for Cor a 14-specific/total IgE), and at the same time, it handled the tolerant cases properly (81% specificity for Ara h 2-specific/total IgE and 74% specificity for Cor a 14specific/total IgE, see Fig E3 in this article's Online Repository at www.jacionline.org).</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>TABLE III .</head><label>III</label><figDesc><div><p><s>Outlier patient characteristics: Food allergies with low component-specific/total IgE ratios (&lt;10% probability levels) and tolerance with high ratios (&gt;90% probability levels)Letters A to I refer to Fig 3.Boldface indicates main predictors (Ara h 2-specific/total IgE and Cor a 14-specific/total IgE ratios).</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Ara h</cell><cell cols="3">Ara h</cell><cell></cell><cell cols="2">Ara h</cell><cell>Ara h</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="3">Total</cell><cell cols="2">Peanut-specific</cell><cell cols="2">1-specific IgE</cell><cell cols="3">2-specific IgE</cell><cell cols="3">3-specific IgE</cell><cell>8-specific IgE</cell></row><row><cell></cell><cell></cell><cell>Age,</cell><cell></cell><cell></cell><cell></cell><cell>IgE</cell><cell>IgE</cell><cell></cell><cell></cell><cell cols="2">%/total</cell><cell cols="3">%/total</cell><cell cols="2">%/total</cell><cell>%/total</cell><cell>Challenge</cell><cell>Other food</cell></row><row><cell>Peanut</cell><cell></cell><cell>sex</cell><cell cols="2">Comorbidity</cell><cell cols="2">kU/L</cell><cell>kU/L</cell><cell></cell><cell>kU/L</cell><cell>IgE</cell><cell cols="2">kU/L</cell><cell cols="3">IgE kU/L</cell><cell>IgE kU/L</cell><cell>IgE</cell><cell>Outcome</cell><cell>symptoms</cell><cell>challenges</cell></row><row><cell>A</cell><cell cols="3">2 y, boy Eczema,</cell><cell></cell><cell></cell><cell>127</cell><cell cols="4">5.7 0.07 0.1%</cell><cell>0</cell><cell></cell><cell cols="4">0.0% 0.6 0.5% 0.01 0.0% Positive Urticaria (&gt;4 hives)</cell><cell>Positive hen's egg</cell></row><row><cell></cell><cell></cell><cell></cell><cell>infection</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>within 15 min</cell><cell>(raw only)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>after ingestion</cell><cell>1 negative</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>hazelnut</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(3 mo earlier)</cell></row><row><cell>B</cell><cell cols="3">6 y, boy Eczema</cell><cell></cell><cell></cell><cell>166</cell><cell cols="4">3.2 0.05 0.0%</cell><cell>0</cell><cell></cell><cell cols="2">0.0% 0</cell><cell></cell><cell>0.0% 0.03 0.0% Positive Repeated vomiting,</cell><cell>Negative almond</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>decrease in blood</cell><cell>(at the same</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>pressure,</cell><cell>time)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>somnolence 1:30 h</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>after ingestion</cell></row><row><cell>C</cell><cell cols="3">1 y, girl Eczema</cell><cell></cell><cell></cell><cell>28</cell><cell cols="3">4.4 0.6</cell><cell>2.3%</cell><cell cols="6">2.8 10.1% 0.3 0.9% 0.01 0.0% Negative</cell><cell>-</cell><cell>Negative cow's</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>milk (at the</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>same time)</cell></row><row><cell>D</cell><cell cols="3">1 y, boy Eczema</cell><cell></cell><cell></cell><cell>5</cell><cell cols="4">1.2 0.05 1.0%</cell><cell cols="4">0.6 12.6% 0</cell><cell></cell><cell>0.2% 0</cell><cell>0.0% Negative</cell><cell>-</cell><cell>-</cell></row><row><cell>E</cell><cell cols="3">1 y, girl Eczema</cell><cell></cell><cell></cell><cell>27</cell><cell cols="3">5.3 0.6</cell><cell>2.0%</cell><cell cols="6">6.3 23.4% 0.1 0.2% 0</cell><cell>0.0% Negative</cell><cell>-</cell><cell>Negative hazelnut</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(at the same</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>time)</cell></row><row><cell>F</cell><cell cols="2">7 y, girl</cell><cell></cell><cell></cell><cell></cell><cell cols="4">413 &gt;100 7.3</cell><cell cols="3">1.8% &gt;100 *</cell><cell></cell><cell cols="3">2.9 0.7% 5.3</cell><cell>1.3% Negative</cell><cell>-</cell><cell>-</cell></row><row><cell>G</cell><cell cols="3">1 y, boy Eczema,</cell><cell></cell><cell></cell><cell>6</cell><cell cols="4">1.1 0.02 0.3%</cell><cell cols="4">1.5 25.0% 0</cell><cell></cell><cell>0.2% 0</cell><cell>0.0% Negative</cell><cell>-</cell><cell>Negative hazelnut</cell></row><row><cell></cell><cell></cell><cell></cell><cell>asthma</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(at the same</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>time)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Cor a</cell><cell cols="2">Cor a</cell><cell></cell><cell cols="2">Cor a</cell><cell>Cor a</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Total</cell><cell cols="2">Hazelnut-specific</cell><cell></cell><cell cols="2">1-specific IgE</cell><cell cols="3">8-specific IgE</cell><cell cols="3">9-specific IgE</cell><cell>14-specific IgE</cell></row><row><cell></cell><cell></cell><cell>Age,</cell><cell>Comor-</cell><cell>IgE</cell><cell></cell><cell cols="2">IgE</cell><cell></cell><cell cols="2">%/total</cell><cell cols="3">%/total</cell><cell></cell><cell cols="2">%/total</cell><cell>%/total</cell><cell>Challenge</cell><cell>Other food</cell></row><row><cell cols="2">Hazelnut</cell><cell>sex</cell><cell>bidity</cell><cell cols="2">kU/L</cell><cell cols="2">kU/L</cell><cell cols="2">kU/L</cell><cell>IgE</cell><cell>kU/L</cell><cell cols="2">IgE</cell><cell>kU/L</cell><cell cols="2">IgE</cell><cell>kU/L</cell><cell>IgE</cell><cell>Outcome</cell><cell>symptoms</cell><cell>challenges</cell></row><row><cell>H</cell><cell></cell><cell>1y ,</cell><cell>Eczema</cell><cell>6</cell><cell></cell><cell></cell><cell>0</cell><cell>0</cell><cell></cell><cell>0.0%</cell><cell>0</cell><cell cols="3">0.0% 0</cell><cell cols="2">0.0% 0</cell><cell>0.0% Positive Urticaria, angioedema,</cell><cell>-</cell></row><row><cell></cell><cell></cell><cell>boy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>somnolence within</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>15 min after</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ingestion</cell></row><row><cell>I</cell><cell></cell><cell>2y ,</cell><cell cols="2">Eczema 256</cell><cell></cell><cell></cell><cell>1.6</cell><cell cols="3">0.01 0.0%</cell><cell>0</cell><cell cols="5">0.0% 1.4 0.5% 0.01 0.0% Positive Urticaria (&gt;4 hives)</cell><cell>Negative cow's</cell></row><row><cell></cell><cell></cell><cell>boy</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>15-30 min after</cell><cell>milk 1 positive</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>ingestion</cell><cell>hen's egg</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(1 y earlier),</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>positive hen's</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>egg, negative</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>almond</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>(at same time)</cell></row></table><note><p><s>*Cannot be calculated.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>TABLE IV .</head><label>IV</label><figDesc><div><p><s>Probability for a positive food challenge at predefined component-specific/total IgE ratios comparing the subgroups with the patients' characteristics (95% CIs)</s></p></div></figDesc><table><row><cell>Peanut</cell><cell>All children</cell><cell>With eczema</cell><cell>Boys only</cell><cell>Age &gt; _4 y</cell></row><row><cell>Ara h 2-specific/total IgE</cell><cell>n 5 207</cell><cell>n 5 147 (71%)</cell><cell>n 5 131 (63%)</cell><cell>n 5 118 (57%)</cell></row><row><cell>0.01%</cell><cell>10% (5% to 17%)</cell><cell>12% (6% to 21%)</cell><cell>10% (4% to 20%)</cell><cell>10% (5% to 21%)</cell></row><row><cell>0.05%</cell><cell>25% (17% to 35%)</cell><cell>27% (18% to 38%)</cell><cell>25% (15% to 37%)</cell><cell>30% (19% to 44%)</cell></row><row><cell>0.1%</cell><cell>35% (26% to 45%)</cell><cell>36% (26% to 48%)</cell><cell>35% (24% to 48%)</cell><cell>42% (29% to 57%)</cell></row><row><cell>0.5%</cell><cell>61% (51% to 71%)</cell><cell>61% (49% to 72%)</cell><cell>63% (49% to 74%)</cell><cell>73% (57% to 85%)</cell></row><row><cell>1%</cell><cell>72% (61% to 81%)</cell><cell>71% (58% to 81%)</cell><cell>73% (60% to 84%)</cell><cell>83% (68% to 92%)</cell></row><row><cell>5%</cell><cell>89% (80% to 94%)</cell><cell>87% (76% to 94%)</cell><cell>90% (79% to 95%)</cell><cell>95% (85% to 98%)</cell></row><row><cell>10%</cell><cell>93% (86% to 97%)</cell><cell>92% (82% to 96%)</cell><cell>94% (85% to 98%)</cell><cell>97% (90% to 99%)</cell></row><row><cell>Hazelnut</cell><cell>All children</cell><cell>With eczema</cell><cell>Boys only</cell><cell>Age &gt; _4 y</cell></row><row><cell>Cor a 14-specific/total IgE</cell><cell>n 5 142</cell><cell>n 5 103 (73%)</cell><cell>n 5 97 (68%)</cell><cell>n 5 80 (56%)</cell></row><row><cell>0.01%</cell><cell>7% (3% to 15%)</cell><cell>8% (3% to 18%)</cell><cell>10% (4% to 22%)</cell><cell>3% (1% to 13%)</cell></row><row><cell>0.05%</cell><cell>17% (10% to 27%)</cell><cell>18% (10% to 31%)</cell><cell>21% (12% to 33%)</cell><cell>11% (4% to 27%)</cell></row><row><cell>0.1%</cell><cell>24% (16% to 35%)</cell><cell>25% (15% to 38%)</cell><cell>28% (18% to 40%)</cell><cell>19% (9% to 36%)</cell></row><row><cell>0.5%</cell><cell>46% (35% to 58%)</cell><cell>47% (34% to 59%)</cell><cell>48% (35% to 61%)</cell><cell>49% (33% to 65%)</cell></row><row><cell>1%</cell><cell>57% (44% to 69%)</cell><cell>57% (43% to 70%)</cell><cell>57% (42% to 71%)</cell><cell>64% (45% to 79%)</cell></row><row><cell>5%</cell><cell>79% (64% to 88%)</cell><cell>78% (62% to 89%)</cell><cell>76% (57% to 88%)</cell><cell>88% (69% to 96%)</cell></row><row><cell>10%</cell><cell>85% (71% to 93%)</cell><cell>85% (69% to 94%)</cell><cell>83% (64% to 93%)</cell><cell>93% (77% to 98%)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>TABLE V .</head><label>V</label><figDesc><div><p><s>Logistic models assessing the role of total and component-specific IgE: Comparison of different coding strategies for total IgE and different adjustments Can the IgE or adjustment variable's contribution to the model be explained by chance alone?</s><s>How well does the complete model discriminate between allergic and nonallergic children?</s><s>àRatio coded in 1 variable.</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Predicting peanut allergy</cell><cell></cell><cell></cell><cell cols="2">Predicting hazelnut allergy</cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Discrimination</cell><cell></cell><cell></cell><cell cols="2">Discrimination</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">Contribution of the</cell><cell>of complete</cell><cell></cell><cell cols="2">Contribution of the</cell><cell>of complete</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell cols="2">variable to the model*</cell><cell>modely</cell><cell cols="3">variable to the model*</cell><cell>modely</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>P values</cell><cell></cell><cell></cell><cell cols="2">P values</cell><cell></cell></row><row><cell>Model</cell><cell>Coding</cell><cell>Adjusted</cell><cell></cell><cell>Total</cell><cell></cell><cell></cell><cell></cell><cell>Total</cell><cell></cell><cell></cell></row><row><cell>no.</cell><cell>of total IgE</cell><cell>for:</cell><cell>Ara h 2</cell><cell cols="2">IgE Adjustment variables</cell><cell>AUC</cell><cell>Cor a 14</cell><cell cols="2">IgE Adjustment variables</cell><cell>AUC</cell></row><row><cell>1</cell><cell>Not in model</cell><cell>-</cell><cell>&lt;.001</cell><cell>-</cell><cell>-</cell><cell>0.93</cell><cell>&lt;.001</cell><cell>-</cell><cell>-</cell><cell>0.89</cell></row><row><cell>2</cell><cell>Ratio</cell><cell>-</cell><cell cols="2">&lt;.001à</cell><cell>-</cell><cell>0.92</cell><cell cols="2">&lt;.001à</cell><cell>-</cell><cell>0.87</cell></row><row><cell>3</cell><cell>Log-transformed</cell><cell>-</cell><cell cols="2">&lt;.001 .030</cell><cell>-</cell><cell>0.93</cell><cell>&lt;.001</cell><cell>.066</cell><cell>-</cell><cell>0.89</cell></row><row><cell>4</cell><cell>Tertiles</cell><cell>-</cell><cell cols="2">&lt;.001 .016</cell><cell>-</cell><cell>0.93</cell><cell>&lt;.001</cell><cell>.071</cell><cell>-</cell><cell>0.89</cell></row><row><cell>5</cell><cell>Tertiles</cell><cell>Age</cell><cell cols="2">&lt;.001 .011</cell><cell>.425</cell><cell>0.93</cell><cell>&lt;.001</cell><cell>.209</cell><cell>.102</cell><cell>0.90</cell></row><row><cell>6</cell><cell>Tertiles</cell><cell cols="3">Age/eczema &lt;.001 .007</cell><cell>.205/.230</cell><cell>0.94</cell><cell>&lt;.001</cell><cell>.209</cell><cell>.104/.928</cell><cell>0.90</cell></row></table><note><p><s>*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head></head><label></label><figDesc><div><p><s>4. Predicted for a positive peanut (upper panel) or hazelnut (lower panel) challenge outcome with Ara h 2-or Cor a 14-specific IgE levels by strata of low, medium, and high total IgE levels (approximate tertiles).Number of peanut challenges in the low, medium, and high total IgE strata were 53, 86, and 68, respectively.Number of hazelnut challenges in the low, medium, and high total IgE strata were 44, 61, and 37, respectively.Calculating specific/total IgE ratios does not improve food challenge outcome predictions.High total IgE levels (&gt;500 kU/L) decrease the probability for a positive challenge at given Ara h 2-and Cor a 14specific IgE levels.Ara h 2-and Cor a 14-specific IgE concentrations are the best single predictors of pediatric peanut and hazelnut allergies, respectively.IgE levels in approximate total IgE tertiles by food challenge outcome.Red solid circles, Positive challenge outcomes; green open circles, negative challenge outcomes.Horizontal lines and shaded areas represent the median and interquartile range in total IgE tertiles, respectively.FIG Component/hazelnut-specific IgE levels in approximate total IgE tertiles by food challenge outcome.Red solid circles, Positive challenge outcomes; green open circles, negative challenge outcomes.Horizontal lines and shaded areas represent the median and interquartile range in total IgE tertiles, respectively.Interdependencies between baseline characteristics (upper half), immunoglobulins (lower half), and challenge outcome.Arrows/solid lines indicate directed links or associations, and dashed lines indicate no association.Reported P values are from TablesE2 and E3.</s></p></div></figDesc><table><row><cell>Key messages</cell><cell>Age</cell><cell></cell></row><row><cell></cell><cell>p&lt;0.001</cell><cell>p=0.551</cell></row><row><cell></cell><cell>Eczema</cell><cell></cell></row><row><cell></cell><cell></cell><cell>p=0.328</cell></row><row><cell>Baseline characterisƟcs</cell><cell>p=0.172</cell><cell>Challenge</cell></row><row><cell>Immunoglobulins</cell><cell></cell><cell>outcome</cell></row><row><cell>Total IgE</cell><cell></cell><cell></cell></row><row><cell cols="2">Component-specific IgE</cell><cell></cell></row><row><cell>FIG E4.</cell><cell></cell><cell></cell></row></table><note><p><s>d d d FIG E1.</s><s>FIG E3.</s><s>Sensitivities and specificities of Ara h 2-specific/total IgE (upper panel) and Cor a 14-specific/total IgE (lower panel) ratios in predicting peanut/hazelnut food challenge outcomes.</s><s>Actual positive (solid gray dots) and negative (gray circles) challenge results are shown.</s><s>The logistic fit is highlighted at predefined levels (colored line and markers), and the pointwise binomial 95% CIs are also shown (colored band and error bars).</s><s>Estimated sensitivities and specificities at predefined cutoffs are shown in the table.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head>TABLE E1 .</head><label>E1</label><figDesc><div><p><s>Baseline characteristics by challenge blinding mode</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell cols="2">Single-or</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">double-blind</cell></row><row><cell></cell><cell cols="2">Open challenges</cell><cell cols="2">challenges</cell></row><row><cell></cell><cell>No.</cell><cell>Percent</cell><cell>No.</cell><cell>Percent</cell></row><row><cell>Total (n 5 349)</cell><cell>228</cell><cell></cell><cell>121</cell><cell></cell></row><row><cell>Female sex</cell><cell>70</cell><cell>30.7</cell><cell>51</cell><cell>42.1</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-1 y</cell><cell>44</cell><cell>19.3</cell><cell>25</cell><cell>20.7</cell></row><row><cell>2-3 y</cell><cell>55</cell><cell>24.1</cell><cell>27</cell><cell>22.3</cell></row><row><cell>4-5 y</cell><cell>54</cell><cell>23.7</cell><cell>24</cell><cell>19.8</cell></row><row><cell>&gt; _6 y</cell><cell>75</cell><cell>32.9</cell><cell>45</cell><cell>37.2</cell></row><row><cell>Comorbidities</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Atopic eczema</cell><cell>168</cell><cell>73.7</cell><cell>82</cell><cell>67.8</cell></row><row><cell>Asthma</cell><cell>91</cell><cell>39.9</cell><cell>26</cell><cell>21.5</cell></row><row><cell>Rhinoconjunctivitis</cell><cell>12</cell><cell>5.3</cell><cell>16</cell><cell>13.2</cell></row><row><cell>Reacted to roasted allergen</cell><cell>122</cell><cell>53.5</cell><cell>75</cell><cell>62.0</cell></row><row><cell>Total IgE</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;100 kU/L</cell><cell>51</cell><cell>22.4</cell><cell>46</cell><cell>38.0</cell></row><row><cell>100-500 kU/L</cell><cell>106</cell><cell>46.5</cell><cell>41</cell><cell>33.9</cell></row><row><cell>&gt;500 kU/L</cell><cell>71</cell><cell>31.1</cell><cell>34</cell><cell>28.1</cell></row><row><cell>Whole allergen-specific IgE</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>&lt;0.35 kU/L (CAP 0)</cell><cell>50</cell><cell>21.9</cell><cell>27</cell><cell>22.3</cell></row><row><cell>0.35 &lt; _ 0.70 kU/L (CAP I)</cell><cell>16</cell><cell>7.0</cell><cell>11</cell><cell>9.1</cell></row><row><cell>0.70 &lt; _ 3.5 kU/L (CAP II)</cell><cell>55</cell><cell>24.1</cell><cell>29</cell><cell>24.0</cell></row><row><cell>3.5 &lt; _ 17.5 kU/L (CAP III)</cell><cell>55</cell><cell>24.1</cell><cell>31</cell><cell>25.6</cell></row><row><cell>&gt; _17.5 kU/L (CAP IV-VI)</cell><cell>52</cell><cell>22.8</cell><cell>23</cell><cell>19.0</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>TABLE E2 .</head><label>E2</label><figDesc><div><p><s>Baseline characteristics by tertiles of total IgE Test for linear association (total IgE as variable, log-transformed).</s><s>for linear association (total IgE as dependent variable, log-transformed, adjusted for age).</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>Total IgE</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>&lt;100 kU/L</cell><cell></cell><cell>100-500 kU/L</cell><cell></cell><cell>&gt;500 kU/L</cell><cell></cell></row><row><cell></cell><cell>No.</cell><cell>Percent</cell><cell>No.</cell><cell>Percent</cell><cell>No.</cell><cell>Percent</cell><cell>P value</cell></row><row><cell>Total (n 5 349)</cell><cell>97</cell><cell></cell><cell>147</cell><cell></cell><cell>105</cell><cell></cell><cell></cell></row><row><cell>Female sex</cell><cell>35</cell><cell>36.1</cell><cell>52</cell><cell>35.4</cell><cell>34</cell><cell>32.4</cell><cell>.411*</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-1 y</cell><cell>39</cell><cell>40.2</cell><cell>23</cell><cell>15.6</cell><cell>7</cell><cell>6.7</cell><cell>&lt;.001*</cell></row><row><cell>2-3 y</cell><cell>30</cell><cell>30.9</cell><cell>40</cell><cell>27.2</cell><cell>12</cell><cell>11.4</cell><cell></cell></row><row><cell>4-5 y</cell><cell>12</cell><cell>12.4</cell><cell>37</cell><cell>25.2</cell><cell>29</cell><cell>27.6</cell><cell></cell></row><row><cell>&gt; _6 y</cell><cell>16</cell><cell>16.5</cell><cell>47</cell><cell>32.0</cell><cell>57</cell><cell>54.3</cell><cell></cell></row><row><cell>Comorbidities</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Atopic eczema</cell><cell>75</cell><cell>77.3</cell><cell>103</cell><cell>70.1</cell><cell>72</cell><cell>68.6</cell><cell>.172</cell></row><row><cell>Asthma</cell><cell>22</cell><cell>22.7</cell><cell>52</cell><cell>35.4</cell><cell>43</cell><cell>41.0</cell><cell>.110</cell></row><row><cell>Rhinoconjunctivitis</cell><cell>4</cell><cell>4.1</cell><cell>10</cell><cell>6.8</cell><cell>14</cell><cell>13.3</cell><cell>.446</cell></row><row><cell>Reacted to roasted allergen</cell><cell></cell><cell>53.6</cell><cell>82</cell><cell>55.8</cell><cell></cell><cell>60.0</cell><cell>.323*</cell></row></table><note><p><s>*</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_8"><head>TABLE E3 .</head><label>E3</label><figDesc><div><p><s>Baseline characteristics by challenge outcome</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell cols="3">Oral food challenge</cell><cell></cell></row><row><cell></cell><cell cols="2">Negative</cell><cell cols="2">Positive</cell><cell></cell></row><row><cell></cell><cell>No.</cell><cell>Percent</cell><cell>No.</cell><cell>Percent</cell><cell>P value</cell></row><row><cell>Total (n 5 349)</cell><cell>217</cell><cell></cell><cell>132</cell><cell></cell><cell></cell></row><row><cell>Female sex</cell><cell>78</cell><cell>35.9</cell><cell>43</cell><cell>32.6</cell><cell>.563*</cell></row><row><cell>Age</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>0-1 y</cell><cell>48</cell><cell>22.1</cell><cell>21</cell><cell>15.9</cell><cell>.551</cell></row><row><cell>2-3 y</cell><cell>51</cell><cell>23.5</cell><cell>31</cell><cell>23.5</cell><cell></cell></row><row><cell>4-5 y</cell><cell>39</cell><cell>18.0</cell><cell>39</cell><cell>29.5</cell><cell></cell></row><row><cell>&gt; _6 y</cell><cell>79</cell><cell>36.4</cell><cell>41</cell><cell>31.1</cell><cell></cell></row><row><cell>Comorbidities</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Atopic eczema</cell><cell>151</cell><cell>69.6</cell><cell>99</cell><cell>75.0</cell><cell>.328*</cell></row><row><cell>Asthma</cell><cell>74</cell><cell>34.1</cell><cell>43</cell><cell>32.6</cell><cell>.816*</cell></row><row><cell>Rhinoconjunctivitis</cell><cell>19</cell><cell>8.8</cell><cell>9</cell><cell>6.8</cell><cell>.685*</cell></row><row><cell>Reacted to roasted</cell><cell>114</cell><cell>52.5</cell><cell>83</cell><cell>62.9</cell><cell>.075*</cell></row><row><cell>allergen</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>*Fisher exact test.Mantel-Haenszel test for linear association.</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL JUNE 2016</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 137, NUMBER 6</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL</note>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">NIAIDsponsored 2010 guidelines for managing food allergy: applications in the pediatric population</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Burks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Boyce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Sicherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Assa'ad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatrics</title>
		<imprint>
			<biblScope unit="volume">128</biblScope>
			<biblScope unit="page" from="955" to="965" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Food allergy: epidemiology, pathogenesis, diagnosis, and treatment</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Sicherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="291" to="308" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Diagnosing peanut allergy with skin prick and specific IgE testing</title>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lack</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="1291" to="1296" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">The diagnosis of food allergy: a systematic review and metaanalysis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Soares-Weiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Takwoingi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Panesar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Werfel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hoffmann-Sommergruber</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="76" to="86" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Highly accurate prediction of food challenge outcome using routinely available clinical data</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dunngalvin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Daly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Cullinane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Stenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Keeton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Erlewyn-Lajeunesse</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="e1" to="3" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Valenta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lidholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Niederberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Hayek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kraft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Gronlund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Allergy</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="896" to="904" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The diagnostic value of specific IgE to Ara h 2 to predict peanut allergy in children is comparable to a validated and updated diagnostic prediction model</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Klemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Otte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Knol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Gmelig-Meyling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">131</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Food-induced anaphylaxis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Jarvinen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="255" to="261" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Provoking allergens and treatment of anaphylaxis in children and adolescents-data from the anaphylaxis registry of German-speaking countries</title>
		<author>
			<persName><forename type="first">S</forename><surname>Hompes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kohli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nemat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Scherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rueff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="568" to="574" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Predictive values of component-specific IgE for the outcome of peanut and hazelnut food challenges in children</title>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grabenhenrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hartl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Beder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kalb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ziegert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="90" to="98" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Increasing the accuracy of peanut allergy diagnosis by using Ara h 2</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Dang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Choo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">V</forename><surname>Licciardi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Koplin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Martin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="1056" to="1063" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Clinical value of component-resolved diagnostics in peanut-allergic patients</title>
		<author>
			<persName><forename type="first">E</forename><surname>Eller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bindslev-Jensen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="190" to="194" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Sensitization to Cor a 9 and Cor a 14 is highly specific for a hazelnut allergy with objective symptoms in Dutch children and adults</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Masthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Mattsson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zuidmeer-Jongejan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lidholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Andersson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Akkerdaas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="page" from="393" to="399" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Interpretation of food specific immunoglobulin E levels in the context of total IgE</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Federly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Dai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Dinakar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy Asthma Immunol</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="20" to="24" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">The size of the disease relevant IgE antibody fraction in relation to &apos;total-IgE&apos; predicts the efficacy of anti-IgE (Xolair) treatment</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Johansson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nopp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Oman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ankerst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Cardell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gronneberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="1472" to="1477" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Gupta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Lau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Hamilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Newhall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol Practice</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="300" to="305" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Utility of the ratio of food-specific IgE/total IgE in predicting symptomatic food allergy in children</title>
		<author>
			<persName><forename type="first">A</forename><surname>Mehl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Verstege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Staden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kulig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nocon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="1034" to="1039" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Can total IgE/specific IgE ratio predict tolerance in cow&apos;s milk allergic children</title>
		<author>
			<persName><forename type="first">A</forename><surname>Machinena-Spera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Giner-Munoz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Alvaro-Lozano</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Iniesta-Benedicto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lozano-Blasco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Piquer-Gibert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Allergy Immunol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="823" to="826" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Total serum IgE level influences oral food challenge tests for IgE-mediated food allergies</title>
		<author>
			<persName><forename type="first">K</forename><surname>Horimukai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tsumura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Nomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Narita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ohya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="334" to="337" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Standardizing double-blind, placebo-controlled oral food challenges: American Academy of Allergy, Asthma &amp; Immunology-European Academy of Allergy and Clinical Immunology PRACTALL consensus report</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gerth Van Wijk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bindslev-Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sicherer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Teuber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Burks</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="1260" to="1274" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">EAACI food allergy and anaphylaxis guidelines: managing patients with food allergy in the community</title>
		<author>
			<persName><forename type="first">A</forename><surname>Muraro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Agache</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sheikh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Akdis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Allergy</title>
		<imprint>
			<biblScope unit="volume">69</biblScope>
			<biblScope unit="page" from="1046" to="1057" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Accurate oral food challenge requires a cumulative dose on a subsequent day</title>
		<author>
			<persName><forename type="first">B</forename><surname>Niggemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lange</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Finger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ziegert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Beyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="page" from="261" to="263" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nicolaou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poorafshar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Winell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kerry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="page" from="e1" to="13" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Quantification of specific IgE to whole peanut extract and peanut components in prediction of peanut allergy</title>
		<author>
			<persName><forename type="first">N</forename><surname>Nicolaou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Belgrave</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Poorafshar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simpson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Custovic</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">127</biblScope>
			<biblScope unit="page" from="684" to="685" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Utility of food-specific IgE concentrations in predicting symptomatic food allergy</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Sampson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="891" to="896" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<monogr>
		<title level="m" type="main">Predicted probability for a positive peanut (upper panel) or hazelnut (lower panel) challenge outcome according to the Ara h 2-or Cor a 14-specific IgE levels by age strata at food challenge (approximate tertiles)</title>
		<author>
			<persName><surname>Fig E5</surname></persName>
		</author>
		<imprint/>
	</monogr>
	<note>Number of peanut challenges in the age strata of 0 to 1, 2 to 5, and 6 or more years were 42, 93, and 72, respectively. Number of hazelnut challenges in the age strata of 0 to 1. 2 to 5, and 6 or more years were 27, 67, and 48, respectively</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
